Global Gemtuzumab Ozogamicin Overview:
AML is the main condition for which Global Gemtuzumab Ozogamicin Market is used as a targeted cancer therapy. It is a monoclonal antibody-drug conjugate (ADC) that mixes calicheamicin, a cytotoxic agent, with another medication. The monoclonal antibody present in gemtuzumab ozogamicin is engineered to identify and attach itself to CD33, a...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek